http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 04 Sep 2024 09:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html <p> CHARLOTTE, N.C.--(BUSINESS WIRE)-- Barings, one of the world’s largest diversified real estate investment managers, announced today that it has provided a $160 million construction loan alongside $155.5 million in C-PACE financing from a subsidiary of Counterpointe Sustainable Advisors (“Counterpointe”) for the development of Habitat, a live-work-thrive campus in Los Angeles with creative office, luxury residential, retail, and an integrated park. </p><p> “We are thrilled to deepen our partnership with Lendlease on this exceptional development, leveraging our in-house expertise in construction lending alongside Counterpointe’s established C-PACE program to offer a customized capital solution,” said Justin Preftakes, Head of Construction Lending http://www.streetinsider.com/Press+Releases/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html Wed, 04 Sep 2024 09:00:00 -0400 A.17475699 LLC O.00673952 http://www.streetinsider.com/Press+Releases/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html <p> CHARLOTTE, N.C.--(BUSINESS WIRE)-- Barings, one of the world’s largest diversified real estate investment managers, announced today that it has provided a $160 million construction loan alongside $155.5 million in C-PACE financing from a subsidiary of Counterpointe Sustainable Advisors (“Counterpointe”) for the development of Habitat, a live-work-thrive campus in Los Angeles with creative office, luxury residential, retail, and an integrated park. </p><p> “We are thrilled to deepen our partnership with Lendlease on this exceptional development, leveraging our in-house expertise in construction lending alongside Counterpointe’s established C-PACE program to offer a customized capital solution,” said Justin Preftakes, Head of Construction Lending http://www.streetinsider.com/Press+Releases/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html Wed, 04 Sep 2024 09:00:00 -0400 A.17475699 LLC O.00673952 http://www.streetinsider.com/Press+Releases/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html <p> CHARLOTTE, N.C.--(BUSINESS WIRE)-- Barings, one of the world’s largest diversified real estate investment managers, announced today that it has provided a $160 million construction loan alongside $155.5 million in C-PACE financing from a subsidiary of Counterpointe Sustainable Advisors (“Counterpointe”) for the development of Habitat, a live-work-thrive campus in Los Angeles with creative office, luxury residential, retail, and an integrated park. </p><p> “We are thrilled to deepen our partnership with Lendlease on this exceptional development, leveraging our in-house expertise in construction lending alongside Counterpointe’s established C-PACE program to offer a customized capital solution,” said Justin Preftakes, Head of Construction Lending http://www.streetinsider.com/Press+Releases/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html Wed, 04 Sep 2024 09:00:00 -0400 A.17475699 LLC O.00673952 http://www.streetinsider.com/Business+Wire/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html <p> CHARLOTTE, N.C.--(BUSINESS WIRE)-- Barings, one of the world’s largest diversified real estate investment managers, announced today that it has provided a $160 million construction loan alongside $155.5 million in C-PACE financing from a subsidiary of Counterpointe Sustainable Advisors (“Counterpointe”) for the development of Habitat, a live-work-thrive campus in Los Angeles with creative office, luxury residential, retail, and an integrated park. </p><p> “We are thrilled to deepen our partnership with Lendlease on this exceptional development, leveraging our in-house expertise in construction lending alongside Counterpointe’s established C-PACE program to offer a customized capital solution,” said Justin Preftakes, Head of Construction Lending http://www.streetinsider.com/Business+Wire/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html Wed, 04 Sep 2024 09:00:00 -0400 A.17475699 LLC O.00673952 http://www.streetinsider.com/Business+Wire/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html <p> CHARLOTTE, N.C.--(BUSINESS WIRE)-- Barings, one of the world’s largest diversified real estate investment managers, announced today that it has provided a $160 million construction loan alongside $155.5 million in C-PACE financing from a subsidiary of Counterpointe Sustainable Advisors (“Counterpointe”) for the development of Habitat, a live-work-thrive campus in Los Angeles with creative office, luxury residential, retail, and an integrated park. </p><p> “We are thrilled to deepen our partnership with Lendlease on this exceptional development, leveraging our in-house expertise in construction lending alongside Counterpointe’s established C-PACE program to offer a customized capital solution,” said Justin Preftakes, Head of Construction Lending http://www.streetinsider.com/Business+Wire/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html Wed, 04 Sep 2024 09:00:00 -0400 A.17475699 LLC O.00673952 http://www.streetinsider.com/Business+Wire/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html <p> CHARLOTTE, N.C.--(BUSINESS WIRE)-- Barings, one of the world’s largest diversified real estate investment managers, announced today that it has provided a $160 million construction loan alongside $155.5 million in C-PACE financing from a subsidiary of Counterpointe Sustainable Advisors (“Counterpointe”) for the development of Habitat, a live-work-thrive campus in Los Angeles with creative office, luxury residential, retail, and an integrated park. </p><p> “We are thrilled to deepen our partnership with Lendlease on this exceptional development, leveraging our in-house expertise in construction lending alongside Counterpointe’s established C-PACE program to offer a customized capital solution,” said Justin Preftakes, Head of Construction Lending http://www.streetinsider.com/Business+Wire/Barings+and+Counterpointe+Provide+%24315.5+Million+in+Construction+Financing+for+Mixed-Use+Development+in+Los+Angeles/23684572.html Wed, 04 Sep 2024 09:00:00 -0400 A.17475699 LLC O.00673952 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Press+Releases/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344 http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html <p class="bwalignc"> <b><i>Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25</i></b> </p><p class="bwalignc"> <b><i>GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology</i></b> </p> <p> MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024. </p><p> “With this spin-off, GRAIL is taking another important step in our journey to shift the paradigm http://www.streetinsider.com/Business+Wire/GRAIL+to+Begin+Trading+on+the+Nasdaq+Stock+Exchange/23389993.html Mon, 24 Jun 2024 16:05:00 -0400 A.02846591 A.03080680 A.06822034 A.20151228 GRAIL GRAL ILMN LLC O.00024621 O.00050653 O.00162324 O.04555430 O.20026344